Literature DB >> 748031

Synthesis of 1,25-dihydroxyvitamin D in the nephrectomized pregnant rat.

Y Weisman, A Vargas, G Duckett, E Reiter, A W Root.   

Abstract

Pregnant rats were maintained on diets either adequate or deficient in vitamin D. On the 20th day of gestation, animals were either nephrectomized bilaterally or sham operated. Immediately therafter, four groups of nephrectomized or sham-operated pregnant rats received iv [26,27-3H]25-hydroxyvitamin D3 ([26,27-3H]25OHD3), while two groups received [1,2-3H,4-14C]D3. The animals were sacrificed 10-24 h later. The distribution of the radiolabeled metabolites of vitamin D3 was determined in extracts of maternal plasma, maternal intestinal tract, placentae, and fetuses after Sephadex LH-20 column chromatography. Both vitamin D3 and 25OHD3 crossed the placenta and entered the fetus. In anephric animals receiving [26,27-3H]-25OHD3, 24,25-dihydroxyvitamin D and a polar peak eluting in the position of 1,25-dihydroxyvitamin D [1,25(OH)2D] and 25,26-dihydroxyvitamin D were identified in extracts of maternal plasma and intestinal tracts and of placentae and fetuses. The identities of 24,25-dihydroxyvitamin D and 1,25 (OH)2D were confirmed by high pressure liquid chromatography. In rats receiving [1,2-3H,4-14C]D3, approximately 50% of the polar metabolite consisted of 1,25(OH)2D. We conclude that the anephric pregnant rat is able to synthesize 1,25(OH)2D, that the fetal portion of the feto-placental unit is the most likely site of production of this hormone, and that this metabolite of vitamin D is able to cross the placenta from the fetus to the mother.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 748031     DOI: 10.1210/endo-103-6-1992

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Authors:  Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs
Journal:  Endocr Rev       Date:  2012-05-17       Impact factor: 19.871

Review 2.  Osteoporosis in pregnancy.

Authors:  W Khovidhunkit; S Epstein
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 3.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

Review 4.  Cytochrome P450-mediated metabolism of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  J Lipid Res       Date:  2013-04-06       Impact factor: 5.922

Review 5.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

6.  Vitamin D-dependent rickets type II.

Authors:  N H Bell
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

Review 7.  Vitamin D therapy in chronic kidney disease and end stage renal disease.

Authors:  Michal L Melamed; Ravi I Thadhani
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

8.  Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination.

Authors:  T D Shultz; J Fox; H Heath; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Vitamin D metabolism during pregnancy and lactation in the rat.

Authors:  B P Halloran; E N Barthell; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue.

Authors:  Y Tanaka; B Halloran; H K Schnoes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.